BioXcel Therapeutics, Inc. (BTAI) › Total AssetsBioXcel Therapeutics, Inc. (BTAI) — Total AssetsAnnual figures by period end, from SEC filings.2017-12-31: $1.35M2018-12-31: $43.55M2019-12-31: $36.39M2020-12-31: $219.94M2021-12-31: $239.44M2022-12-31: $205.85M2023-12-31: $73.70M2024-12-31: $38.34M2025-12-31: $44.92M$44.92M2017-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$44.92M+17.2%2026-03-27Balance as of period end2024-12-31$38.34M-48.0%2026-03-27Balance as of period end2023-12-31$73.70M-64.2%2025-03-28Balance as of period end2022-12-31$205.85M-14.0%2024-03-22Balance as of period end2021-12-31$239.44M+8.9%2023-03-16Balance as of period end2020-12-31$219.94M+504.4%2022-03-11Balance as of period end2019-12-31$36.39M-16.4%2021-03-12Balance as of period end2018-12-31$43.55M+3113.9%2020-03-09Balance as of period end2017-12-31$1.35M—2019-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)